ETHK Labs Inc. (HKG:1931)

Market Cap	1.03B -61.7%
Revenue (ttm)	3.14B -10.8%
Net Income	38.87M -86.6%
EPS	0.02 -87.6%
Shares Out	1.60B
PE Ratio	26.68
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	767,000
Open	0.6600
Previous Close	0.6700
Day's Range	0.6300 - 0.6700
52-Week Range	0.6300 - 12.8600
Beta	-0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About ETHK Labs

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the cl...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2016
• Employees: 910
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1931

Financial Performance

In 2025, ETHK Labs's revenue was 2.82 billion, a decrease of -10.81% compared to the previous year's 3.16 billion. Earnings were 34.93 million, a decrease of -86.59%.

Financial numbers in CNY